RE:RE:RE:RE:RE:What a bleedOops, not sure how to post a pic here.
but on slide 35 of July 2020 corporate presentation:
-Beta Glucan Q1 2021 Complete enrolment in cholesterol reducer study H2 2021 Top-line results from cholesterol reducer study
-Avenanthramide H2 2020 Initiate bioavailability study of pharmaceutical grade tablets
-PGX Mid 2021 Complete commercial scale-up
-Corporate H2 2020 Chemical Complex (NCC) Out-Licensing Deal, Ongoing Uplist to a national U.S. Exchange